Cunaplus_M.Faba / iStock via Getty Images Zealand Pharma shares (OTCPK: ZLDPF) Denmark Biotech, the first participant’s obstructive therapy Petrelintide announced the medium-stage trial for obesity therapy, the subject of the company’s recent license Source link